Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.73M Sell
23,241
-60
-0.3% -$4.85K 0.09% 283
2019
Q2
$1.98M Buy
+23,301
New +$1.87M 0.11% 221
2017
Q4
Sell
-166,950
Closed -$19.5M 650
2017
Q3
$19.5M Sell
166,950
-1,510
-0.9% -$191K 0.44% 63
2017
Q2
$21.2M Buy
168,460
+4,980
+3% +$634K 0.49% 51
2017
Q1
$21.9M Buy
163,480
+31,025
+23% +$3.95M 0.51% 42
2016
Q4
$13.3M Buy
132,455
+129,255
+4,039% +$12.6M 0.32% 95
2016
Q3
$302K Hold
3,200
0.01% 608
2016
Q2
$256K Sell
3,200
-1,100
-26% -$85.4K 0.01% 633
2016
Q1
$312K Sell
4,300
-79,700
-95% -$5.94M 0.01% 571
2015
Q4
$9.11M Buy
84,000
+62,225
+286% +$6.94M 0.21% 135
2015
Q3
$2.4M Buy
21,775
+17,275
+384% +$1.94M 0.09% 250
2015
Q2
$469K Buy
+4,500
New +$466K 0.02% 485
2013
Q3
Sell
-9,185
Closed -$202K 574
2013
Q2
$202K Buy
+9,185
New +$201K 0.01% 520

Other funds holding INCY

Boston Advisors's INCY Position: Q3 2019 in Review

Boston Advisors reduced its Incyte (INCY) stake by 0.26% in Q3 2019, selling an estimated $4.85K and leaving 23,241 shares worth $1.73M. The position accounts for 0.09% of the portfolio, ranked #283.

Boston Advisors first reported a position in INCY in Q2 2013 and has held it in 13 quarters since. The position peaked at $21.9M in Q1 2017. 496 funds tracked by Wall St. Rank hold INCY as of Q3 2019.

  • Boston Advisors held 23,241 shares of Incyte worth $1.73M as of Q3 2019.
  • Boston Advisors sold 60 Incyte shares in Q3 2019, an estimated $4.85K.
  • Incyte made up 0.09% of Boston Advisors's portfolio in Q3 2019, its #283 holding.
  • Boston Advisors first reported a position in Incyte in Q2 2013 and has held it in 13 quarters since.
  • Boston Advisors's Incyte position peaked at $21.9M in Q1 2017.
  • 496 funds tracked by Wall St. Rank held Incyte as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.